Turnstone Biologics Corp
NASDAQ:TSBX
Income Statement
Earnings Waterfall
Turnstone Biologics Corp
Revenue
|
19.3m
USD
|
Operating Expenses
|
-78.3m
USD
|
Operating Income
|
-59m
USD
|
Other Expenses
|
3.8m
USD
|
Net Income
|
-55.2m
USD
|
Income Statement
Turnstone Biologics Corp
Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
93
N/A
|
93
N/A
|
19
-79%
|
|
Operating Income | ||||
Operating Expenses |
(146)
|
(165)
|
(78)
|
|
Selling, General & Administrative |
(27)
|
(32)
|
(18)
|
|
Research & Development |
(120)
|
(134)
|
(60)
|
|
Operating Income |
(54)
N/A
|
(73)
-35%
|
(59)
+19%
|
|
Pre-Tax Income | ||||
Total Other Income |
2
|
3
|
4
|
|
Pre-Tax Income |
(52)
N/A
|
(70)
-33%
|
(55)
+20%
|
|
Net Income | ||||
Tax Provision |
(0)
|
(0)
|
0
|
|
Income from Continuing Operations |
(52)
|
(70)
|
(55)
|
|
Net Income (Common) |
(52)
N/A
|
(70)
-33%
|
(55)
+21%
|
|
EPS (Diluted) |
-2.37
N/A
|
-4.01
-69%
|
-4.78
-19%
|